Based on BCR::ABL1 transcript kinetics and variant allele frequency (VAF) of mutations in CRGs, it is presumed that these mutations are present in CML cells, which is in line with previous works [19, 25]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.